Mid banner advertisement: BDO
Advertisement: RSM
Advertisement: Bradfield Centre mid
Barr Ellison Solicitors – commercial property
Advertisement: Cambridge Network
Advertisement: Wild Knight Vodka
Advertisement: TTP
RealVNC mid banner careers
Advertisement EY mid banner
Advertisement: Mogrify
Advertisement Cambridge China Centre
ARM Innovation Hub
RealVNC mid-banner general
13 May, 2019 - 09:55 By Kate Sweeney

Cambridge robodocs technology hailed a success after first operations on humans

CMR Surgical's robotics arm

Robotics technology from Cambridge has been used in operations on humans for the first time with the Indian surgeons involved reporting successful procedures.

CMR Surgical’s robotics arm,Versius®, was deployed in 30 laparoscopic procedures as part of a clinical trial at Deenanath Mangeshkar Hospital & Research Center in Pune, India by consultant oncologist and general surgeon Dr Dhananjay Kelkar and his team.

The surgeries consisted of minor, intermediate and major gynaecological and upper gastrointestinal procedures. No adverse events were reported as a result of the use of Versius after a 30-day follow up.

Dr Kelkar said: “As the first surgeon to conduct a laparoscopic procedure in a clinical setting using Versius, I can say that the system has been shown to be highly effective and has significant potential for bringing minimal access surgery to patients here in India and around the world.

“The Versius® Surgical Robotic System is flexible and fits easily into our busy operating environment. We have a high demand for surgical care and are committed to bringing the most innovative technologies to our patients.”

Following the completion of the first-in-human series, CMR Surgical will work closely with surgeons and hospitals on a clinical introduction of the Versius® Surgical Robotic System to bring the benefits of minimal access (keyhole) surgery to patients around the world.

Mark Slack, chief medical officer at CMR Surgical, said: “This first-in-human series is a significant milestone in bringing Versius to operating theatres around the world.

“These initial results are positive and we look forward to further advancing our mission to bring the benefits of minimal access surgery to everyone who needs it.

“This series is part of our drive for the responsible introduction of surgical robotic systems that puts safety and effectiveness above all else.”

The clinical trial was conducted in line with CMR Surgical’s collaboration with the IDEAL framework which provides an international benchmark for each stage of the surgical innovation process, including clinical trials.

The first-in-human series is being carried out under internationally recognised clinical trial protocols as set out by good clinical practice. 

Newsletter Subscription

Stay informed of the latest news and features